Solutions
Technology
PlayMolecule
®
The Drug Design Environment for AI agents
ACEMD
®
The Toolkit for Molecular Simulations and Machine Learning Potentials
QuantumBind
®
The Drug Engineering Platform for Small Molecules
Research & Development
Expanding the Boundaries of what is Possible
PlayMolecule AI
Pipeline
Company
About
Learn about us
Investors
Partnering for innovation
Contact Us
For information and support
Blog
News and updates by our team
Careers
Join our mission
info@acellera.com
From Conversation to Computation: PlayMolecule AI Now Executes Computational Workflows
Read more
Contact us
By clicking
“Accept”
, you agree to the storing of cookies on your device to enhance site navigation and analyze site usage.
Deny
Accept
WHat's New
The Blog
News and updates by our team.
2
min read
From Conversation to Computation: PlayMolecule AI Now Executes Computational Workflows
Read post
3
min read
Stop Searching, Start Asking: Introducing "Speak to a Protein"
Read post
2
min read
Acellera and Psivant Collaborate to Develop Transformative Computational Drug Discovery Approaches Using AI and Quantum Simulations
Read post
2
min read
Advancing Drug Discovery with AceFF 1.0
Read post
1
min read
Release of ACEMD 4.0.0: Advancing Machine Learning for Molecular Dynamics Simulations
Read post
1
min read
Acellera CCPBioSim IndustryTalk: Applications of MD Simulations in Drug Discovery Pipelines
Read post
1
min read
Professor Andrew White Joins Acellera Therapeutics’ Advisory Board
Read post
1
min read
ACEGEN: A Reinforcement Learning Toolkit for Generative Drug Design
Read post
1
min read
Exploring the Complexities of PURA Syndrome: Insights from Molecular Dynamics
Read post
1
min read
Experimental-accuracy RBFE calculations (call for collaborations)
Read post
Next
.png)
